HGH supplement warning letter
This article was originally published in The Tan Sheet
Executive Summary
Global Internet Alliance's purported human growth hormone dietary supplement T-10 HGH may not be sold as a supplement because growth hormone is approved as a drug and no evidence exists that the substance is safe and effective for the uses promoted by Global Internet Alliance, FDA says in a Feb. 18 warning letter. T-10 HGH was marketed on the Internet for anti-aging and disease treatment, the letter notes. In addition, product's delivery form as an oral spray to be absorbed directly into the mucus membrane does not fit the definition of a supplement, the agency tells the Corpus Christi, Texas firm...
You may also be interested in...
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.